EE200100329A - Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod - Google Patents

Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod

Info

Publication number
EE200100329A
EE200100329A EEP200100329A EEP200100329A EE200100329A EE 200100329 A EE200100329 A EE 200100329A EE P200100329 A EEP200100329 A EE P200100329A EE P200100329 A EEP200100329 A EE P200100329A EE 200100329 A EE200100329 A EE 200100329A
Authority
EE
Estonia
Prior art keywords
preparation
benzisoxazoles
phenones
composition
Prior art date
Application number
EEP200100329A
Other languages
English (en)
Inventor
Edmond Josephine Kennis Ludo
Carolus Mertens Josephus
Maria Aloysius Pieters Serge
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE200100329A publication Critical patent/EE200100329A/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200100329A 1998-12-21 1999-12-14 Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod EE200100329A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204358 1998-12-21
PCT/EP1999/010054 WO2000037466A1 (en) 1998-12-21 1999-12-14 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS

Publications (1)

Publication Number Publication Date
EE200100329A true EE200100329A (et) 2002-08-15

Family

ID=8234508

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100329A EE200100329A (et) 1998-12-21 1999-12-14 Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod

Country Status (30)

Country Link
US (1) US6576640B1 (et)
EP (1) EP1140934B1 (et)
JP (1) JP4717216B2 (et)
KR (2) KR100657540B1 (et)
CN (1) CN1154646C (et)
AR (1) AR021924A1 (et)
AT (1) ATE251622T1 (et)
AU (1) AU765751B2 (et)
BG (1) BG65162B1 (et)
BR (1) BR9916427A (et)
CA (1) CA2355716C (et)
CZ (1) CZ294532B6 (et)
DE (1) DE69911995T2 (et)
EA (1) EA003606B1 (et)
EE (1) EE200100329A (et)
ES (1) ES2209553T3 (et)
HK (1) HK1045686B (et)
HR (1) HRP20010444A2 (et)
HU (1) HUP0104812A3 (et)
ID (1) ID28967A (et)
IL (2) IL143830A0 (et)
NO (1) NO317892B1 (et)
NZ (1) NZ511411A (et)
PL (1) PL196958B1 (et)
SK (1) SK285560B6 (et)
TR (1) TR200101813T2 (et)
TW (1) TWI229673B (et)
UA (1) UA71938C2 (et)
WO (1) WO2000037466A1 (et)
ZA (1) ZA200105067B (et)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2451606A1 (en) * 2001-07-05 2003-01-16 Pharmacia & Upjohn Company (hetero) aryl substituted benzofurans as 5-ht ligands
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
AU2005233456A1 (en) 2004-04-12 2005-10-27 Taisho Pharmaceutical Co., Ltd. Cyclic amine compound
CA2617102A1 (en) * 2005-07-28 2007-02-08 Bristol-Myers Squibb Company Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists
CN117327065A (zh) * 2022-06-23 2024-01-02 北京大学 作为多巴胺d2/3受体调节剂的咔唑类衍生物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3419568A (en) * 1966-12-07 1968-12-31 Abbott Lab Derivatives of 1,2,3,4-tetrahydro-5h-pyrido[4,3b]indoles
US3718657A (en) * 1970-12-03 1973-02-27 Abbott Lab Certain-2-substituted-1,2,3,4-tetrahydro-beta or gamma carbolines
JPS4729395U (et) * 1971-04-26 1972-12-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
AR207799A1 (es) * 1974-04-01 1976-10-29 Pfizer Procedimiento para preparar azaciclo(3,4-a)-n-fenilindoles-2-substituidos
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
FR2570701B1 (fr) 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4985422A (en) 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
WO1994008040A1 (en) * 1992-09-25 1994-04-14 Synaptic Pharmaceutical Corporation Dna encoding human alpha 1 adrenergic receptors and uses thereof
US5508306A (en) * 1992-11-13 1996-04-16 Synaptic Pharmaceutical Corporation Aromatic amine derivatives
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
UA52681C2 (uk) 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
ID28967A (id) 2001-07-19
ES2209553T3 (es) 2004-06-16
EP1140934A1 (en) 2001-10-10
JP2002533341A (ja) 2002-10-08
HRP20010444A2 (en) 2002-06-30
HUP0104812A3 (en) 2003-12-29
NZ511411A (en) 2002-12-20
TWI229673B (en) 2005-03-21
JP4717216B2 (ja) 2011-07-06
AR021924A1 (es) 2002-09-04
KR100657540B1 (ko) 2006-12-14
NO20012783D0 (no) 2001-06-06
UA71938C2 (en) 2005-01-17
IL143830A0 (en) 2002-04-21
WO2000037466A1 (en) 2000-06-29
CZ20012120A3 (cs) 2001-10-17
SK285560B6 (sk) 2007-03-01
NO317892B1 (no) 2004-12-27
PL348421A1 (en) 2002-05-20
ATE251622T1 (de) 2003-10-15
CZ294532B6 (cs) 2005-01-12
EA003606B1 (ru) 2003-06-26
ZA200105067B (en) 2002-06-20
AU2432700A (en) 2000-07-12
CA2355716A1 (en) 2000-06-29
IL143830A (en) 2007-07-24
PL196958B1 (pl) 2008-02-29
NO20012783L (no) 2001-06-06
BG105521A (en) 2001-12-29
EP1140934B1 (en) 2003-10-08
SK8582001A3 (en) 2001-12-03
BG65162B1 (bg) 2007-04-30
AU765751B2 (en) 2003-09-25
HK1045686A1 (en) 2002-12-06
BR9916427A (pt) 2001-09-04
US6576640B1 (en) 2003-06-10
CN1331692A (zh) 2002-01-16
CA2355716C (en) 2010-05-18
DE69911995T2 (de) 2004-09-02
KR20060093139A (ko) 2006-08-23
DE69911995D1 (de) 2003-11-13
HK1045686B (zh) 2005-04-01
TR200101813T2 (tr) 2001-12-21
CN1154646C (zh) 2004-06-23
KR20010075650A (ko) 2001-08-09
HUP0104812A2 (hu) 2002-04-29
EA200100709A1 (ru) 2001-12-24

Similar Documents

Publication Publication Date Title
PL341733A1 (en) Prolonged release composition, method of obtaining same and application thereof
EE04739B1 (et) Tienüülasolüülalkoksüetaanamiinderivaadid, nende ja nende soolade valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ning vaheühend ja selle valmistamismeetod
EE05086B1 (et) Primidiini derivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus
GB9903216D0 (en) Preservative compounds,compositions and methods of making and using the same
DE69918871D1 (de) Zementzusatzmittel und Zementzusammensetzung
ID29236A (id) Benzopiran-benzopiran dan benzoksepin-benzoksepin, komposisi-komposisi famaseutikal yang mengandungnya, dan proses penyiapannya
FI962908L (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö
EE200000621A (et) Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine
EE04490B1 (et) Ühend, selle valmistamise meetod ning kasutamine meditsiinis
ITMI20000701A0 (it) Composizione di gomma procedimento per produrre la stessa e manicottoutilizzante la composizione di gomma
CY2009017I1 (el) Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
ID30238A (id) Komposisi-komposisi amifostin amorf yang stabil dan metode-metode untuk pembuatan dan penggunaannya
EE04717B1 (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
EE200000159A (et) Vees redispergeeritav pulbriline kompositsioon, selle valmistamismeetod ja taastatud lateks ning nende kasutamine
EE9900152A (et) Poorne kattepigment ning selle valmistamismeetod
EE03682B1 (et) Asendatud bensimidasooli derivaadid, protsessid nende valmistamiseks ning nende kasutamine
EE200000767A (et) Asendatud triasolopüridasiini derivaat, selle valmistamismeetod ja kasutamine ning farmatseutiline kompositsioon
EE04087B1 (et) Antimükootiline kompositsioon, selle kasutamine ja valmistamismeetod ning antimükootiline toode
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
EE03554B1 (et) Mikropoorne kristalne materjal, selle valmistamismeetod ja kasutamine detergentkompositsioonides
EE05187B1 (et) Hirudiini prekursor, selle kasutamine ja meetod Leu-hirudiini valmistamiseks
DE60028757D1 (de) Polyolefinzusammensetzung, verfahren zur herstellung und die verwendung davon
EE04770B1 (et) Tritsüklilised delta3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
EE03798B1 (et) Söödalisandi valmistamise meetod, söödalisand ja selle kasutamine
EE200100329A (et) Bensisoksasoolid ja fenoonid, nende valmistamismeetod ja kasutamine ning kompositsioon ja selle valmistamismeetod